NIH-funded research R21 grant

Understanding how HTLV-1 virus spreads and assembles

Official title: Imaging of HTLV-1 by cryo-CLEM

Funded at University of Minnesota · NIH-10827963 · Data updated 2026-11-12

This study is looking at how the HTLV-1 virus spreads and causes health issues, with the goal of finding better ways to treat people affected by it.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startMay 1, 2023
Project endApril 30, 2026
Funding year2024
Award (this year)$193,750
NIH project number5R21DE032878-02
Project IDNIH-10827963 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals infected with HTLV-1, particularly those experiencing symptoms related to adult T-cell leukemia or other associated conditions.

Less likely to help

Patients who are not infected with HTLV-1 or do not exhibit related health issues may not benefit from this research.

What this research studies

This research investigates the Human T-cell leukemia virus (HTLV-1), which affects millions globally and is linked to serious health conditions like adult T-cell leukemia and other inflammatory diseases. The study focuses on the virus's unique ability to spread through direct cell-to-cell contact, known as the virological synapse, and aims to uncover the mechanisms behind its assembly and transmission. By using advanced imaging techniques, researchers hope to gain insights into how the virus replicates and spreads, which could lead to better understanding and treatment options for those infected. Patients may benefit from the findings that could improve therapeutic strategies against HTLV-1-related diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and prevention strategies for patients affected by HTLV-1 and its associated diseases.

How similar studies have gone: Previous research has shown promise in understanding virus transmission through cell interactions, but this specific approach to studying HTLV-1 is relatively novel.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Mansky, Louis M. — University of Minnesota
  • Study coordinator: Mansky, Louis M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.